Learn About Acute Myeloblastic Leukemia with Maturation

What is the definition of Acute Myeloblastic Leukemia with Maturation?
A rare, acute myeloid leukemia characterized by evidence of granulocytic maturation and more than 20% of blast cells in the bone marrow and/or peripheral blood. The maturing non-blast granulocytic cells account for greater than or equal to 10% and monocytic cells less than or equal to 20% of the bone marrow cells. Various degrees of anemia, thrombocytopenia, or pancytopenia are present. Frequent clinical manifestations include fatigue, fever, bleeding disorders, and organomegaly, especially hepatosplenomegaly.
Save information for later
Sign Up
What are the alternative names for Acute Myeloblastic Leukemia with Maturation?
  • Acute myeloblastic leukemia with maturation
  • AML M2
  • Acute myeloblastic leukemia M2
  • Acute myeloblastic leukemia type 2
  • LAM M2
Who are the top Acute Myeloblastic Leukemia with Maturation Local Doctors?
Elite
Highly rated in
32
conditions
Oncology
Hematology Oncology
Hematology

University of Texas System

Physicians Referral Service

1515 Holcombe Blvd 
Houston, TX 77030

Tapan Kadia is an Oncologist and a Hematologist Oncology doctor in Houston, Texas. Dr. Kadia has been practicing medicine for over 21 years and is rated as an Elite doctor by MediFind in the treatment of Acute Myeloblastic Leukemia with Maturation. He is also highly rated in 32 other conditions, according to our data. His top areas of expertise are Acute Myeloid Leukemia, Myelodysplastic Syndrome MDS, Leukemia, and Acute Myeloblastic Leukemia with Maturation. He is licensed to treat patients in Texas. Dr. Kadia is currently accepting new patients.

Elite
Highly rated in
29
conditions
Hematology Oncology
Hematology
Oncology

Moffitt Cancer Center

Moffitt Cancer Center

12902 Usf Magnolia Drive 
Tampa, FL 33612

Jeffrey Lancet is a Hematologist Oncology specialist and a Hematologist in Tampa, Florida. Dr. Lancet has been practicing medicine for over 30 years and is rated as an Elite doctor by MediFind in the treatment of Acute Myeloblastic Leukemia with Maturation. He is also highly rated in 29 other conditions, according to our data. His top areas of expertise are Acute Myeloid Leukemia, Myelodysplastic Syndrome MDS, Leukemia, and Acute Myeloblastic Leukemia without Maturation. He is licensed to treat patients in Florida. Dr. Lancet is currently accepting new patients.

 
 
 
 
Learn about our expert tiers
Learn more
Elite
Highly rated in
40
conditions
Oncology
Hematology Oncology

Memorial Hematology Lymphoma Group

675 N Saint Clair St 
Chicago, IL 60611

Martin Tallman is an Oncologist and a Hematologist Oncology doctor in Chicago, Illinois. Dr. Tallman has been practicing medicine for over 42 years and is rated as an Elite doctor by MediFind in the treatment of Acute Myeloblastic Leukemia with Maturation. He is also highly rated in 40 other conditions, according to our data. His top areas of expertise are Acute Myeloid Leukemia, Acute Promyelocytic Leukemia, Leukemia, and Hairy Cell Leukemia. He is licensed to treat patients in Illinois. Dr. Tallman is currently accepting new patients.

What are the latest Acute Myeloblastic Leukemia with Maturation Clinical Trials?
Salsalate + Venetoclax/Decitabine for Patients With Acute Myelogenous Leukemia or Advanced Myelodysplasia/Myeloproliferative Disease
Match to trials
Find the right clinical trials for you in under a minute
Get started
Randomized, Multicenter, Phase 3 Study of Azacytidine (AZA) + Venetoclax as Maintenance Therapy in Patients With AML in Remissionin Younger Adults With Favorable-risk AML in First Remission After Conventional Chemotherapy
Who are the sources who wrote this article ?

Published Date: May 02, 2022
Published By: Genetic and Rare Diseases Informnation Center

What are the Latest Advances for Acute Myeloblastic Leukemia with Maturation?
Real-world analysis of main clinical outcomes in patients with polycythemia vera treated with ruxolitinib or best available therapy after developing resistance/intolerance to hydroxyurea.
Phase II trial of cytarabine and mitoxantrone with devimistat in acute myeloid leukemia.
Tired of the same old research?
Check Latest Advances
Single-agent 5-azacytidine as post-transplant maintenance in high-risk myeloid malignancies undergoing allogeneic hematopoietic cell transplantation.